Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

New Study Demonstrates What Makes A Cranberry Supplement Effective at UTI Management--Soluble PAC

Ellura by Trophikos reports: New independent research shows the influence of formulation and proanthocyanidins (PAC) solubility on in vitro and ex vivo P-fimbriated E. coli bacterial Anti-Adhesion Activity (AAA).


News provided by

ellura

May 06, 2021, 08:00 ET

Share this article

Share toX

Share this article

Share toX

ATLANTA, May 6, 2021 /PRNewswire/ -- A new, groundbreaking study clarifies why some cranberry supplements are effective at managing recurrent Urinary Tract Infections (2 in 6 months or 3 in 12 months), while others are not, arming healthcare providers with much needed clarity on how to advise their patients. For the first time, scientists confirmed cranberry products made with soluble proanthocyanidins (PACs), demonstrating higher Anti-Adhesion Activity (AAA) of uropathogenic bacteria in urine compared to products with insoluble PAC after intake of the products over a one-week period.

Continue Reading
Only soluble PACs from concentrated cranberry juice extract are responsible for Anti Adhesion Activity
Only soluble PACs from concentrated cranberry juice extract are responsible for Anti Adhesion Activity

In the study funded by Rutgers University and published in the Journal of Dietary Supplements, Rutgers Research Scientist, Amy B. Howell, PhD, Jean-François Dreyfus, MD, PhD, and practicing urologist Bilal Chughtai, MD of Weill Cornell Medicine reported that "water soluble PAC, sourced directly from cranberry juice extract has a direct impact on in vitro and ex vivo AAA of P-fimbriated E. coli bacteria." The authors explained, "the bacterial AAA of urine following cranberry juice extract consumption interrupts the initial step in the infection process, a potentially important mechanism for UTI prevention. Preventing infection in this way, rather than killing bacteria, may help reduce resistant uropathogenic bacterial strains."

"Cranberry, Vaccinium macrocarpon, is already widely utilized by consumers for maintenance of urinary tract health." However, since cranberry supplements are not regulated by the FDA, there is no oversight on what must be included for efficacy. As a result, supplements on the market are often formulated using different components of the cranberry that may or may not be effective. This new study explains that this is a key reason for why there is high variability in AAA across these products.

Previously, Dr. Bilal Chughtai & Researcher Amy Howell compared AAA of 9 commercially available cranberry supplements in a study published in

American Journal of Obstetrics and Gynecology

 in 2016   and discovered significant variability among products. That study elucidated why some supplements don't work—not enough Anti Adhesion Activity, noting that "products containing 36 mg of PAC have the best AAA," though there was insufficient evidence to explain the discrepancy in AAA variability even among those containing 36 mg of PAC.

We now know 36 mg of PAC is only part of the story. 

The source of the PACs is equally important —which part of the cranberry it comes from. In this new study, the scientists concluded that water-soluble PACs found in concentrated cranberry juice extract elicit the highest AAA in urine after intake.

Anti-Adhesion testing of PACRAN, which is comprised of PACs from every part of the cranberry, versus GIKACRAN with PACs taken only from the juice concentrate extract, and fractions of each supplement containing the distinct molecular classes of compounds in each supplement confirmed that only the soluble PACs from the juice concentrate are responsible for AAA. As explained in the study, "The 36 mg PAC level often reported in cranberry products is specifically indicative of the soluble PAC measured only with the DMAC/A2 reference standard and is the recommended daily intake amount according to large meta-analyses on cranberry clinical trials for UTI prevention (Jepson et al., 2012; Jepson, 2013). The majority of AAA is linked to polyphenolic compounds in cranberry, especially A-type (PAC) found in the water-soluble juice portion of cranberry fruit (Howell et al. 1998, Foo 2000, Gupta 2007, Gupta 2012) and their metabolites (de Llano et al. 2015; Mena et al. 2017)."

The AAA testing for both soluble and insoluble PACs reveals a significant difference between them, with AAA of soluble PAC being almost three times higher than insoluble PAC. "High concentrations of soluble PAC per serving in CJD [concentrated cranberry juice extract] correlated with 94 percent ex vivo urinary AAA, while the lower 23 percent AAA value for WCFD [whole fruit components] was likely due to the low soluble PAC content per serving. When PACs are insoluble, they do not have AAA. The PACs that come from the pomace products (the pulp, seeds, stems, skin of the berry) are insoluble, because the pomace is fibrous. The PACs get stuck in the cellulose matrix, and can't be easily extracted out, especially by the human body...The insoluble, non-extractable PACs complexed with cellulose fibers in the cranberry skins that remain after the juicing process (Gullickson et al., 2019; Roopchand et al., 2013) have not shown an effect on bacterial adhesion."

The study provides long-desired direction for healthcare providers to advise their patients: To get the most anti-adhesion benefit, look for a supplement made from cranberry juice extract.

"This study demonstrates the important differences in formulating cranberry supplements for urinary tract health," said Brian Flynn, MD, UC Health, Denver. "The results show that the type of cranberry fruit component in the supplement directly influences its effectiveness and should guide consumers and healthcare providers when choosing cranberry supplements for urinary tract health."

"Since day one, the ellura team has sought to deliver reliable solutions for UTI health, made with the best ingredients, and backed by scientific research," said Kevin Wade, EVP of Clinical and Physician Development and co-founder of Trōphikōs, makers of ellura. "We remain committed to delivering the best of nature, powered by science."

About ellura®
Backed by 19 clinical studies and 11 traditional herbal medicine approvals worldwide, ellura, is made from GIKACRAN, and has been available in the US for more than 10 years. ellura is a clinically proven, daily supplement for non-antibiotic management of patients with recurrent urinary tract infections. ellura's complex proprietary double extraction manufacturing process, extracting PAC only from the pure cranberry juice concentrate, results in the highest-shown levels of soluble A-type PAC to date and the highest level of bacterial Anti-Adhesion Activity compared to other available supplements on the market. For studies including dosing, pediatric, catheter and surgical, and more information, visit ellurahcp.com.

Contact Info--
Tamara Brown
SVP, Marketing
[email protected] 
+1 (404) 618-4990

SOURCE ellura

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.